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ABSTRACT  
The UK’s Breast Screening Programme is 27 years old and many experienced breast radiologists are now retiring, 
coupled with an influx of new screening personnel.  It is important to the ongoing Programme that new mammography 
readers are quickly up to the skill level of experienced readers.  This raises the question of how quickly the necessary 
cancer detection skills are learnt.  All breast screening radiologists in the UK read educational training sets of 
challenging FFDM images (the PERFORMS® scheme) yearly to maintain and improve their performance in real life 
screening. Data were examined from the PERFORMS® annual scheme for 54 new screeners, 55 screeners who have 
been screening for one year and also for more experienced screeners (597 screeners). Not surprisingly, significant 
differences in cancer detection rate were found between new readers and both of the other groups. Additionally, the 
performance of 48 new readers who have now been screening for about a year and have taken part twice in the 
PERFORMS® scheme were further examined where again a significant difference in cancer detection was found. These 
data imply that cancer detection skills are learnt quickly in the first year of screening. Information was also examined 
concerning the volume of cases participants read and other factors. 
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1. INTRODUCTION  
The UK’s Breast Screening Programme screens all women aged 50-70 every three years.  In England alone, the latest 
data show that each year more than two million women undergo breast cancer screening1. Nationally the number of 
radiologists and advanced practitioners (technologists) who undertake screening is over 700. The Royal College of 
Radiologists have recommended that a radiologist must read at least 5,000 cases a year in order to participate in the 
national screening programme2. Despite this large number of cases, an individual radiologist can possibly only expect on 
average to see a malignant case about once or twice in a working week when they are operating as a first screen reader 
(the UK employs a double reading policy in screening).  
Therefore, it is extremely important for radiologists to work to the best of their abilities and to maintain vigilance in 
reading mammograms. To this aim, all breast screening radiologists in the UK read self-assessment sets of challenging 
FFDM digital breast screening cases (the PERFORMS® scheme) yearly to maintain and improve their performance in 
real life screening3. New case sets are regularly carefully constructed.  Examining carefully selected sets of difficult 
screening cases, coupled with immediate confidential feedback on how mammography readers identified key 
mammographic signs of abnormality, and how their screening decisions agreed with an expert panel of radiologists as 
well as large numbers of their radiological colleagues, is key to understanding their skills and improving their cancer 
detection - especially for new screening personnel4. 
The UK Screening Programme is 27 years old and has a deserved international reputation for its high quality.  When 
screening was first introduced many radiologists went into this domain and have now become experts, several are also 
considered international experts.  However, many of these radiologists are now reaching retirement age and new 
screening personnel are coming into the Programme.  The question is - will the overall quality of the Programme 
diminish with the loss of this expert body of personnel?  To examine this issue, data from the PERFORMS® scheme 
were examined for different groups of participants with different levels of experience of breast screening. 
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M=89.78%; AUC: M=0.8554; CS: M=85.45%; PPV: M=69.93%). Also it was found that CD, CR, AUC and NPV were 
significantly higher for ‘2+ time’ participants (Group C) compared to second-time participants (Group B) with CD: 
p<0.05; CR: p<0.05; AUC: p<0.01;  NPV: p<0.05; CS: p=n.s.; PPV: p=n.s. 
 
 
3.2 False negative responses  
To understand what may underlie the key performance differences between the groups the number of false negative 
responses were investigated, based on the various abnormalities’ feature types (Table 1). These instances involve cases 
where participants have either identified a feature but then not interpreted that case as a recall case (misinterpreted the 
feature information) or they have not identified any feature and have returned that case to normal screen (undetected the 
feature). In general, the ability to identify types of abnormal features correctly increased as the number of participations 
in PERFORMS® schemes increased. This did not hold true for well-defined masses.   
Table 1. False negative responses by feature types. 
 Mean % False Negative Responses 
Feature Type Group A  Group B Group C 
Architectural Distortion 16.14 11.17 8.21 
Calcification 16.14 10.13 6.03 
Ill Defined Mass 28.52 18.18 14.47 
Spiculate Mass 32.04 19.27 16.06 
Well Defined Mass 44.44 27.27 30.82 
 
For Architectural Distortion, Calcification, Ill Defined Mass and Spiculate Mass, there were statistically significant 
differences between groups as determined by one-way ANOVA (Architectural Distortion: F(2,703) = 9.438, p<0.01; 
Calcification: F(2,703) = 17.755, p<0.01; Ill Defined Mass: F(2,703) = 25.711, p<0.01 ; Spiculate Mass: 
F(2,703)=35.894, p<0.01).  
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For Well Defined Mass, there was no significant difference between groups (F(2,703)=2.389, p=0.092). Tukey post hoc 
tests revealed that the mean false negative rates for Architectural Distortion, Calcification, Ill Defined Mass and 
Spiculate Mass were significantly higher for first time participants: Group A (Architectural Distortion: M= 16.14%, 
p<0.01; Calcification: M= 16.14%, p<0.01; Ill Defined Mass: M=28.52%, p<0.01; Spiculate Mass: M=32.04%, p<0.01; 
Well Defined Mass: M=44.44%, p=0.098) compared to 2+ time participants: Group C (Architectural Distortion: M= 
8.21%; Calcification: M= 6.03%; Ill Defined Mass: M=14.47%; Spiculate Mass: M=16.06%; Well Defined Mass: 
M=30.82%).  
The mean false negative rates for Calcification, Ill Defined Mass and Spiculate Mass were significantly lower for 2nd 
time participants: Group B (Calcification: M=10.13%, p=0.034; Ill Defined Mass: M=18.18%, p<0.01; Spiculate Mass: 
M=19.27%, p<0.01; Architechtural Distortion: M=11.17%, p=0.129; Well Defined Mass: M=27.27%, p=0.131) 
compared to 1st time participants: Group A. No significant difference between Group B and Group C was found for all 
feature types (p>0.05). 
 
3.3 Examples of difficult cases 
To further illustrate differences between the three groups, data from five very difficult malignant cases (based on Group 
A responses) and which had been reported as false negative cases by the Group A are shown in Table 2. This further 
indicates that, in general, the more experienced individuals performed better on the difficult malignant cases, making 
fewer false negative responses. 
Table 2. False negative responses for these five difficult cases. 
 Mean % False Negative Responses 
Malignant Case  Group A  Group B Group C 
1 51.85 29.09 15.24 
2 50 34.55 29.15 
3 48.15 20 20.10 
4 44.44 27.27 30.82 
5 40.74 36.36 27.30 
 
 
3.4 Detecting suspicious areas 
Data of the three groups were also analysed in terms of correctly identifying the areas of interest (AOIs), which had 
been pre-determined by the expert panel of radiologists, to ascertain their abilities in detecting these suspicious areas. 
Overall, the mean value of detecting at least one AOI on an abnormal breast for Group A, Group B and Group C were 
approximately 77%, 84% and 86% respectively.  
For example, for the case shown in Figure 3, there are three abnormality areas on the two mammograms. The 
abnormalities are defined in these images by the AOIs constructed around them by the expert panel and the participants’ 
responses are shown by the individual points.  Some 27 individuals (50%) from Group A could not detect any of the 
AOIs (one is an Architectural Distortion and the other is a Spiculate Mass and these are both highly suspicious of breast 
cancer); however, this rate for Group B and Group C are 29% and 16% respectively. 
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